Valuation : Theraclion

Market Cap 51.18M 59.47M 48.19M 43.91M 82.15M 5.66B 82.48M 571M 221M 2.88B 223M 218M 9.13B P/E 2024
-2.66x
P/E 2025 -6.33x
Enterprise Value 59.03M 68.6M 55.58M 50.64M 94.75M 6.53B 95.13M 659M 255M 3.33B 258M 252M 10.53B EV / Sales 2024
22.5x
EV / Sales 2025 55.4x
Free-Float
39.01%
Yield 2024 *
-
Yield 2025 -
1 day+2.19%
1 week-9.09%
Current month-6.67%
1 month+15.89%
3 months-15.66%
6 months+22.81%
Current year+16.28%
1 week 0.67
Extreme 0.67
0.76
1 month 0.59
Extreme 0.59
0.8
Current year 0.4
Extreme 0.402
0.93
1 year 0.4
Extreme 0.402
1.25
3 years 0.14
Extreme 0.1416
1.25
5 years 0.14
Extreme 0.1416
2.22
10 years 0.14
Extreme 0.1416
6.3
Manager TitleAgeSince
Chief Executive Officer - 24/05/2023
Director of Finance/CFO - -
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member - 22/06/2021
Director/Board Member - 28/01/2022
Director/Board Member - 29/06/2023
Date Insider Type Main position Quantity % Market Cap. Importance
26/8/26 Exercice

Director

266,139 0.3627%
Change 5-day change 1-year change 3-year change Capi.($)
+2.19%-9.09%-3.58%+14.38% 58.25M
+0.44%+0.86%+24.21%+16.87% 223B
-0.19%-1.01%+3.13%-17.52% 144B
+0.88%-4.34%-24.84%+18.45% 124B
-0.04%-6.49%-58.42%-16.54% 65.19B
-0.62%-5.03%+7.44%+16.35% 49.99B
-0.79%-1.55%-18.62%-13.39% 50.49B
-1.43%-3.45%+12.97%+26.98% 41.4B
+0.47%-0.25%+30.85%+53.59% 39.59B
-2.87%-1.03%+108.80%+29.45% 31.87B
Average -0.21%-2.84%+8.19%+12.86% 76.95B
Weighted average by Cap. -0.06%-1.80%+4.71%+8.78%

Financials

2024 2025
Net sales 830K 965K 782K 712K 1.33M 91.81M 1.34M 9.26M 3.58M 46.77M 3.62M 3.54M 148M 652K 758K 614K 559K 1.05M 72.1M 1.05M 7.28M 2.81M 36.73M 2.85M 2.78M 116M
Net income -5.76M -6.69M -5.42M -4.94M -9.24M -637M -9.28M -64.25M -24.83M -324M -25.12M -24.58M -1.03B -5.69M -6.61M -5.36M -4.88M -9.13M -629M -9.17M -63.5M -24.54M -321M -24.83M -24.29M -1.02B
Net Debt 3.41M 3.96M 3.21M 2.93M 5.47M 377M 5.5M 38.06M 14.71M 192M 14.88M 14.56M 609M 7.85M 9.12M 7.39M 6.74M 12.6M 868M 12.65M 87.62M 33.87M 442M 34.26M 33.52M 1.4B
Logo Theraclion
Theraclion specializes in developping, manufacturing and marketing echotherapy equipment associating therapy with focused ultrasound (HIFU) and monitoring by ultrasound. The company provides Echopulse, a device for non-invasive and outpatient treatment of mammary fibroadenoma and thyroid nodules.Net sales break down by activity as follows: - sale of consumables (52.8%); - sale of equipment (28.8%); - provision of after-sales services (18.4%). The vast majority of net sales are earned abroad.
Employees
36
Date Price Change Volume
10/09/26 EUR 0.7000 +2.19% 42,969
08/09/26 EUR 0.6850 -1.30% 19,120
07/09/26 EUR 0.6940 -5.19% 49,171
04/09/26 EUR 0.7320 0.00% 175,499
03/09/26 EUR 0.7320 +8.77% 246,255

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALTHE Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!